These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 7666553)

  • 1. Lack of evidence of phenotypic complementation of E1A/E1B-deleted adenovirus type 5 upon superinfection by wild-type virus in the cotton rat.
    Oualikene W; Gonin P; Eloit M
    J Virol; 1995 Oct; 69(10):6518-24. PubMed ID: 7666553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E1A and E1B proteins inhibit inflammation induced by adenovirus.
    Schaack J; Bennett ML; Colbert JD; Torres AV; Clayton GH; Ornelles D; Moorhead J
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3124-9. PubMed ID: 14976240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the respiratory epithelium of normals and individuals with cystic fibrosis for the presence of adenovirus E1a sequences relevant to the use of E1a- adenovirus vectors for gene therapy for the respiratory manifestations of cystic fibrosis.
    Eissa NT; Chu CS; Danel C; Crystal RG
    Hum Gene Ther; 1994 Sep; 5(9):1105-14. PubMed ID: 7833370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species.
    Eloit M; Adam M
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1583-9. PubMed ID: 9049365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells.
    Rao XM; Tseng MT; Zheng X; Dong Y; Jamshidi-Parsian A; Thompson TC; Brenner MK; McMasters KM; Zhou HS
    Cancer Gene Ther; 2004 Sep; 11(9):585-93. PubMed ID: 15338010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
    Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
    Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matching complementing functions of transformed cells with stable expression of selected viral genes for production of E1-deleted adenovirus vectors.
    Howe JA; Pelka P; Antelman D; Wilson C; Cornell D; Hancock W; Ramachandra M; Avanzini J; Horn M; Wills K; Sutjipto S; Ralston R
    Virology; 2006 Feb; 345(1):220-30. PubMed ID: 16246392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trans complementation of an E1A-deleted adenovirus with codelivered E1A sequences to make recombinant adenoviral producer cells.
    Goldsmith KT; Curiel DT; Engler JA; Garver RI
    Hum Gene Ther; 1994 Nov; 5(11):1341-8. PubMed ID: 7893805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective effects of E1B-defective adenoviruses and adenovirus E1A mutants in deficient mouse primary embryonic fibroblasts.
    Martin Duque P; Parada C; Guinea J; Sanchez-Prieto R; Ramon Y Cajal S
    Int J Oncol; 2001 Jun; 18(6):1163-7. PubMed ID: 11351246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically modified adenoviruses against gliomas: from bench to bedside.
    Gomez-Manzano C; Yung WK; Alemany R; Fueyo J
    Neurology; 2004 Aug; 63(3):418-26. PubMed ID: 15304571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Readthrough activation of early adenovirus E1b gene transcription.
    Maxfield LF; Spector DJ
    J Virol; 1997 Nov; 71(11):8321-9. PubMed ID: 9343185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional relatedness between the E1a and E1b regions of group C and group D human adenoviruses.
    Jannun R; Chinnadurai G
    Virus Res; 1987 Feb; 7(1):33-48. PubMed ID: 2951934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice.
    Zsengeller ZK; Wert SE; Hull WM; Hu X; Yei S; Trapnell BC; Whitsett JA
    Hum Gene Ther; 1995 Apr; 6(4):457-67. PubMed ID: 7612702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A.
    Savelyeva I; Dobbelstein M
    Oncogene; 2011 Feb; 30(7):865-75. PubMed ID: 20935676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Splicing of Human Adenovirus 5 E1A RNA Expressed in
    Graves D; Akkerman N; Bachus S; Pelka P
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.
    Takahashi M; Sato T; Sagawa T; Lu Y; Sato Y; Iyama S; Yamada Y; Fukaura J; Takahashi S; Miyanishi K; Yamashita T; Sasaki K; Kogawa K; Hamada H; Kato J; Niitsu Y
    Mol Ther; 2002 May; 5(5 Pt 1):627-34. PubMed ID: 11991754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementation of a defective human adenovirus by an otherwise incompatible ovine adenovirus recombinant carrying a functional E1A gene.
    Lockett LJ; Both GW
    Virology; 2002 Mar; 294(2):333-41. PubMed ID: 12009875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects.
    Kim J; Kim JH; Choi KJ; Kim PH; Yun CO
    Hum Gene Ther; 2007 Sep; 18(9):773-86. PubMed ID: 17725410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.
    Sparer TE; Wynn SG; Clark DJ; Kaplan JM; Cardoza LM; Wadsworth SC; Smith AE; Gooding LR
    J Virol; 1997 Mar; 71(3):2277-84. PubMed ID: 9032363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas.
    Jiang H; Gomez-Manzano C; Alemany R; Medrano D; Alonso M; Bekele BN; Lin E; Conrad CC; Yung WK; Fueyo J
    Neoplasia; 2005 Jan; 7(1):48-56. PubMed ID: 15720816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.